MedTrace Logo

Optimize RV Selective Site Pacing Clinical Trial

NCT00422669 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 205

Last updated 2013-01-31

Study results available
· View outcomes & findings →

Summary

The purpose of the Optimize RV study is to determine the long-term effect of selective site pacing. Selective site pacing refers to which area of the right ventricle the lead is placed. The goal of select site pacing is to improve how the heart contracts when paced in the ventricle. By pacing in select sites, it is possible to better copy the natural pattern of contraction of the heart.

Conditions

  • Cardiac Pacing, Artificial
  • Cardiac Pacemaker, Artificial

Interventions

DEVICE

Medtronic Dual-Chamber Pacemaker

A Medtronic market-approved dual-chamber implantable pulse generator (IPG)

DEVICE

Medtronic SelectSecure 3830 Lead

Medtronic market-approved SelectSecure Model 3830 bipolar pacing lead

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Optimize RV Team · Medtronic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States
  • Canada
  • China
  • Israel
  • Italy
  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00422669 on ClinicalTrials.gov